Harej Hrkać, A.; Pilipović, K.; Belančić, A.; Juretić, L.; Vitezić, D.; Mršić-Pelčić, J.
The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury. Pharmaceuticals 2024, 17, 1313.
https://doi.org/10.3390/ph17101313
AMA Style
Harej Hrkać A, Pilipović K, Belančić A, Juretić L, Vitezić D, Mršić-Pelčić J.
The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury. Pharmaceuticals. 2024; 17(10):1313.
https://doi.org/10.3390/ph17101313
Chicago/Turabian Style
Harej Hrkać, Anja, Kristina Pilipović, Andrej Belančić, Lea Juretić, Dinko Vitezić, and Jasenka Mršić-Pelčić.
2024. "The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury" Pharmaceuticals 17, no. 10: 1313.
https://doi.org/10.3390/ph17101313
APA Style
Harej Hrkać, A., Pilipović, K., Belančić, A., Juretić, L., Vitezić, D., & Mršić-Pelčić, J.
(2024). The Therapeutic Potential of Glucagon-like Peptide 1 Receptor Agonists in Traumatic Brain Injury. Pharmaceuticals, 17(10), 1313.
https://doi.org/10.3390/ph17101313